NYSEARCA:LABD Direxion Daily S&P Biotech Bear 3x Shares (LABD) Price, Holdings, & News $4.45 -0.26 (-5.52%) Closing price 04:10 PM EasternExtended Trading$4.46 +0.01 (+0.22%) As of 07:47 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipShort InterestBuy This Stock About Direxion Daily S&P Biotech Bear 3x Shares (NYSEARCA:LABD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LABD alerts:Sign Up Key Stats Today's Range$4.41▼$4.7550-Day Range$4.45▼$6.7952-Week Range$4.41▼$16.05Volume20.96 million shsAverage Volume14.98 million shsMarket Capitalization$71.29 millionAssets Under Management$70.76 millionDividend Yield6.07%Net Expense Ratio1.07%Aggregate RatingN/A ETF Overview The Direxion Daily S&P Biotech Bear 3X Shares (LABD) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index. LABD was launched on May 28, 2015 and is managed by Direxion. Read More Direxion Daily S&P Biotech Bear 3x Shares ExpensesTypeLABDHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.75%0.56%0.56%0.51%0.53%Other Expenses0.33%0.47%0.56%0.59%0.56%Total Expense1.08%0.75%0.76%0.74%0.73%Fee Waiver-0.01%-0.67%-0.66%-0.71%-0.63%Net Expense1.07%0.60%0.63%0.58%0.60% Receive LABD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Direxion Daily S&P Biotech Bear 3x Shares and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LABD ETF News HeadlinesDirexion Daily S&P Biotech Bear 3x Shares Stock to Reverse Split on Monday, September 29th (NYSEARCA:LABD)September 17, 2025 | americanbankingnews.comDirexion Announces Reverse Split of NVDD, EDZ, FAZ, LABD & SPXSAugust 29, 2025 | finance.yahoo.comStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.September 22 at 2:00 AM | Paradigm Press (Ad)Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0370June 24, 2025 | msn.comTSLL, LABD: Big ETF OutflowsMay 13, 2025 | nasdaq.comDirexion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.1264December 24, 2024 | msn.comSee More Headlines LABD ETF - Frequently Asked Questions How have LABD shares performed this year? Direxion Daily S&P Biotech Bear 3x Shares' stock was trading at $7.25 on January 1st, 2025. Since then, LABD shares have decreased by 38.6% and is now trading at $4.45. When did Direxion Daily S&P Biotech Bear 3x Shares' stock split? Direxion Daily S&P Biotech Bear 3x Shares shares reverse split on Friday, August 28th 2020.The 1-20 reverse split was announced on Monday, July 27th 2020. The number of shares owned by shareholders was adjusted after the market closes on Thursday, August 27th 2020. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split. Who are Direxion Daily S&P Biotech Bear 3x Shares' major shareholders? Direxion Daily S&P Biotech Bear 3x Shares' top institutional investors include Jump Financial LLC (1.09%), Group One Trading LLC (0.28%), Tower Research Capital LLC TRC (0.26%) and Envestnet Asset Management Inc. (0.09%). How do I buy shares of Direxion Daily S&P Biotech Bear 3x Shares? Shares of LABD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Direxion Daily S&P Biotech Bear 3x Shares own? Based on aggregate information from My MarketBeat watchlists, some other companies that Direxion Daily S&P Biotech Bear 3x Shares investors own include Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Micron Technology (MU), Direxion Daily S&P Biotech Bull 3x Shares (LABU), NVIDIA (NVDA) and Intel (INTC). Fund Details IssuerDirexion Fund NameDirexion Daily S&P Biotech Bear 3x Shares Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:LABD Inception Date5/28/2015 Fund ManagerPaul Brigandi, Tony Ng WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkS&P Biotechnology Select Industry Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings14 Fund Statistics Assets Under Management$70.76 million Average Daily Volume$15.89 million Discount/Premium0.00% Leveraged-3.00 Administrator, Advisor and Custodian AdministratorU.S. Bancorp Fund Services, LLC AdvisorRafferty Asset Management, LLC CustodianThe Bank of New York Mellon Corporation DistributorForeside Fund Services, LLC Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerVirtu Financial Options OptionableOptionable Options Volume965 Put Options475 Call Options490 Short Interest1,200,000 shs Miscellaneous Outstanding Shares16,020,000Beta-2.40 Creation Unit50,000 Creation Fee$250.00 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report Top 9 LABD HoldingsDreyfus Govt Cash Man InsHolding Weight: 44.79%Goldman Sachs Sterling FixInc Port IncHolding Weight: 36.16%Goldman Sachs Fin Gov 465 InstitutHolding Weight: 19.42%Dreyfus Trsry Securities Cash MgmtHolding Weight: 10.67%Citi CollateralHolding Weight: -0.61%Jpm CollateralHolding Weight: -1.43%Baml CollateralHolding Weight: -2.01%S&P Biotechnology Select Industry Index SwapHolding Weight: -3.27%Goldman CollateralHolding Weight: -3.71%Full Holdings Details This page (NYSEARCA:LABD) was last updated on 9/22/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Direxion Daily S&P Biotech Bear 3x Shares Please log in to your account or sign up in order to add this asset to your watchlist. Share Direxion Daily S&P Biotech Bear 3x Shares With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
